Currently available evidence weakly supports the inference that testosterone use in men is not associated with important cardiovascular effects .
OBJECTIVE To conduct a systematic review and meta- analysis of r and omized trials that assessed the effect of testosterone use on  cardiovascular events and risk factors in men with different degrees of and rogen deficiency .
Therapeutic effect of andriol on serum lipids and apolipoproteins in elderly male coronary heart disease patients.
The elevated estradiol/testosterone ( E2/T ) ratio had been proved to be a risk factor for coronary heart disease ( CHD ) in elderly males and to exert an adverse effect on lipid metabolism . We conducted a r and omized cross-over study to determine the effect of And riol , a new and rogenic preparation , on plasma lipids and apolipoproteins . The results showed a significant difference in most parameters between patients receiving And riol and the control group : in the former , serum T level was elevated significantly ( P < 0.001 ) , E2 level was unchanged ( P > 0.05 ) and the E2/T ratio was reduced ( P > 0.05 ) . Blood levels of total cholesterol ( TC ) and triglyceride ( TG ) were lowered dramatically ( P < 0.001 ) and high density lipoprotein cholesterol ( HDL-ch ) was raised ( P < 0.05 ) , but apolipoprotein-AI ( APO-AI ) and B ( APO-B ) levels remained unchanged . No obvious side effect was observed in those who took And riol
Currently available evidence weakly supports the inference that testosterone use in men is not associated with important cardiovascular effects .
OBJECTIVE To conduct a systematic review and meta- analysis of r and omized trials that assessed the effect of testosterone use on  cardiovascular events and risk factors in men with different degrees of and rogen deficiency .